VITAL THERAPIES INC Contracts & Agreements

Employment Agreement, dated December 13, 2024, between Immunic, Inc. and Dr. Daniel Vitt (Filed With SEC on December 18, 2024)

Addendum No. 6, dated August 29, 2024, to Employment Agreement, dated April 17, 2020, between Immunic, Inc. and Duane Nash (Filed With SEC on September 3, 2024)

Description of Registrants Securities (Filed With SEC on February 22, 2024)

Form of Pre-Funded Warrant (Filed With SEC on January 5, 2024)

Securities Purchase Agreement, dated January 4, 2024, by and among the Company and the Investors (Filed With SEC on January 5, 2024)

Fifth Addendum, dated December 18, 2023, to Service Agreement between Immunic AG and Dr. Daniel Vitt (Filed With SEC on December 21, 2023)

Fifth Addendum, dated December 18, 2023, to Service Agreement between Immunic AG and Dr. Andreas Muehler (Filed With SEC on December 21, 2023)

Employment Agreement, dated December 18, 2023, between Immunic, Inc. and Dr. Andreas Muehler (Filed With SEC on December 21, 2023)

Fifth Addendum, dated December 18, 2023, to Service Agreement between Immunic AG and Dr. Hella Kohlhof (Filed With SEC on December 21, 2023)

Addendum No. 5, dated October 17, 2023, to Employment Agreement, dated April 17, 2020, between Immunic, Inc. and Duane Nash (Filed With SEC on October 18, 2023)

Description of Registrant's Securities (Filed With SEC on February 23, 2023)

Service Agreement dated August 22, 2016 between Immunic AG and Dr. Andreas Muehler (Filed With SEC on February 23, 2023)

Service Agreement dated September 29, 2016 between Immunic AG and Daniel Vitt (Filed With SEC on February 23, 2023)

Fourth Addendum, dated January 16, 2023, to Service Agreement between Immunic AG and Dr. Daniel Vitt (Filed With SEC on January 20, 2023)

Fourth Addendum, dated January 16, 2023, to Service Agreement between Immunic AG and Dr. Andreas Muehler (Filed With SEC on January 20, 2023)

Fourth Addendum, dated January 16, 2023, to Service Agreement between Immunic AG and Dr. Hella Kohlhof (Filed With SEC on January 20, 2023)

Addendum No. 4 to Employment Agreement, dated December 28, 2022, between Immunic, Inc. and Duane Nash (Filed With SEC on December 30, 2022)

Description of Registrant's Securities (Filed With SEC on November 3, 2022)

Form of Pre-Funded Warrant (Filed With SEC on October 11, 2022)

Securities Purchase Agreement, dated October 10, 2022, by and among the Company and the Purchasers (Filed With SEC on October 11, 2022)

Description of Registrant's Securities (Filed With SEC on August 4, 2022)

Description of Registrant's Securities (Filed With SEC on May 10, 2022)

Sales Agreement, dated as of May 2, 2022, between SVB Securities LLC and Immunic, Inc (Filed With SEC on May 2, 2022)

Addendum No. 3 to Employment Agreement, dated March 15, 2022, between Immunic, Inc. and Duane Nash (Filed With SEC on March 16, 2022)

Description of Registrant's Securities (Filed With SEC on February 24, 2022)

Third Addendum, dated January 5, 2022, to Service Agreement between Immunic AG and Dr. Daniel Vitt (Filed With SEC on January 10, 2022)

Third Addendum, dated January 5, 2022, to Service Agreement between Immunic AG and Dr. Andreas Muehler (Filed With SEC on January 10, 2022)

Third Addendum, dated January 5, 2022, to Service Agreement between Immunic AG and Dr. Hella Kohlhof (Filed With SEC on January 10, 2022)

Description of Registrant's Securities (Filed With SEC on November 4, 2021)

Employment Agreement, dated October 14, 2021, by Patrick Walsh and Immunic, Inc (Filed With SEC on October 15, 2021)

Description of Registrant's Securities (Filed With SEC on August 6, 2021)

Underwriting Agreement, dated July 15, 2021, by and between Immunic, Inc. and Piper Sandler & Co (Filed With SEC on July 19, 2021)

Second Addendum, dated June 10, 2021, to Service Agreement between Immunic AG and Dr. Daniel Vitt (Filed With SEC on June 14, 2021)

Second Addendum, dated June 10, 2021, to Service Agreement between Immunic AG and Dr. Andreas Muehler (Filed With SEC on June 14, 2021)

Employment Agreement, dated June 10, 2021, between Immunic, Inc. and Dr. Andreas Muehler (Filed With SEC on June 14, 2021)

Employment Agreement, dated June 10, 2021, between Immunic, Inc. and Glenn Whaley (Filed With SEC on June 14, 2021)

Description of Registrant's Securities (Filed With SEC on May 6, 2021)

Addendum No. 2 to Employment Agreement, dated April 15, 2021, between Immunic, Inc. and Duane Nash (Filed With SEC on April 19, 2021)

Settlement Agreement, dated March 31, 2021, between Immunic AG and 4SC AG (Filed With SEC on March 31, 2021)

Description of Registrant's Securities (Filed With SEC on February 26, 2021)

Sales Agreement, dated as of December 29, 2020, between SVB Leerink LLC and Immunic, Inc (Filed With SEC on January 4, 2021)

Amendment Letter, dated November 11, 2020 (Filed With SEC on November 13, 2020)

Addendum to Employment Agreement dated October 15, 2020, between Immunic, Inc. and Duane Nash (Filed With SEC on November 6, 2020)

Finance Contract, dated October 19, 2020, between Immunic, Inc., Immunic AG and European Investment Bank (Filed With SEC on October 20, 2020)

Form of Guarantee Agreement between Immunic, Inc., Immunic AG and European Investment Bank (Filed With SEC on October 20, 2020)

Underwriting Agreement, dated August 4, 2020, by and between Immunic, Inc. and SVB Leerink LLC (Filed With SEC on August 10, 2020)

Placement Agency Agreement, dated June 10, 2020, between the Company and the Placement Agent (Filed With SEC on June 12, 2020)

Form of Securities Purchase Agreement, dated June 10, 2020, between the Company and the investors party thereto (Filed With SEC on June 12, 2020)

Letter Agreement, dated April 23, 2020, between the Company and the Placement Agent (Filed With SEC on April 27, 2020)

Form of Securities Purchase Agreement, dated April 23, 2020, between the Company and the investors party thereto (Filed With SEC on April 27, 2020)

Confidential Severance Agreement and Full and General Release dated April 17, 2020 (Filed With SEC on April 20, 2020)

Employment Agreement dated April 17, 2020 (Filed With SEC on April 20, 2020)

Addendum, dated September 4, 2019, to Service Agreement between Immunic AG and Dr. Daniel Vitt (Filed With SEC on September 5, 2019)

Addendum, dated September 4, 2019, to Service Agreement between Immunic AG and Dr. Manfred Grppel (Filed With SEC on September 5, 2019)

Employment Agreement, dated as of July 15, 2019, by and between Sanjay Patel and Immunic, Inc (Filed With SEC on July 17, 2019)

Sales Agreement, dated as of July 17, 2019, between SVB Leerink LLC and Immunic, Inc (Filed With SEC on July 17, 2019)

Option and License Agreement, dated September 27, 2018, between Immunic AG and Daiichi Sankyo Company, Limited (Filed With SEC on July 17, 2019)

Asset Purchase Agreement, dated May 13, 2016, between Immunic AG and 4SC AG (Filed With SEC on July 17, 2019)

Form of Indemnification Agreement (Filed With SEC on July 17, 2019)

Vitt Employment Agreement, dated as of March 23, 2016, by and between Dr. Daniel Vitt and Immunic AG (Filed With SEC on July 17, 2019)

Grppel Employment Agreement, dated as of August 26, 2016, by and between Dr. Manfred Grppel and Immunic AG (Filed With SEC on July 17, 2019)

Forms of Lock-Up Agreement (Filed With SEC on April 15, 2019)

First Amendment to Asset Purchase Agreement between RH Cell Therapeutics Corp. and Vital Therapies, Inc. dated as of March 27, 2019 (Filed With SEC on April 10, 2019)

Second Amendment to Asset Purchase Agreement between RH Cell Therapeutics Corp. and Vital Therapies, Inc. dated as of April 4, 2019 (Filed With SEC on April 10, 2019)

Asset Purchase Agreement by and between RH Cell Therapeutics Corp and Vital Therapies, Inc., dated March 13, 2019 (Filed With SEC on March 19, 2019)

Lease Assignment Agreement by and between ViaCyte, Inc. and Vital Therapies, Inc (Filed With SEC on March 19, 2019)

Form of RSU Award Agreement under 2014 Equity Incentive Plan (Filed With SEC on January 14, 2019)

Form of Amendment No. 1 to Change of Control and Severance Agreement (Filed With SEC on January 14, 2019)

Investment and Subscription Agreement, dated as of January 6, 2019, among Immunic AG and its Shareholders (Filed With SEC on January 7, 2019)

Exchange Agreement, dated as of January 6, 2019 by and among Vital Therapies, Inc., Immunic AG, and the shareholders of Immunic AG (Filed With SEC on January 7, 2019)

Investment Banking Agreement between Ladenburg Thalmann & Co. Inc. and Vital Therapies, Inc., dated October 11, 2018 (Filed With SEC on October 12, 2018)

Transition Agreement and Release between the Registrant and Terence E. Winters, dated December 4, 2017 (Filed With SEC on March 13, 2018)

Employment Letter Agreement between the Registrant and Russel J. Cox, dated November 30, 2017 (Filed With SEC on March 13, 2018)

Amended Global Stock Option Agreement under 2014 Equity Incentive Plan (Filed With SEC on March 13, 2018)

2017 Inducement Equity Incentive Plan (Filed With SEC on October 25, 2017)

U.S. Stock Option Agreement under 2017 Inducement Equity Incentive Plan (Filed With SEC on October 25, 2017)

INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE NET DATED OCTOBER 18, 2016BY AND BETWEEN VITAL THERAPIES, INC., A DELAWARE CORPORATIONAND R.E. HAZARD CONTRACTING COMPANY, A CALIFORNIA... (Filed With SEC on May 9, 2017)

8,750,000 Shares (Filed With SEC on March 23, 2017)

FIRST AMENDMENT TO LEASE (Carmel Point) (Filed With SEC on August 29, 2016)

VITAL THERAPIES, INC. OUTSIDE DIRECTOR COMPENSATION POLICY Adopted and approved May 13, 2013 As Amended March 18, 2015, December 18, 2015 and May 24, 2016 (Filed With SEC on May 27, 2016)

VITAL THERAPIES, INC. OUTSIDE DIRECTOR COMPENSATION POLICY Adopted and approved May 13, 2013 As Amended March 18, 2015 and December 18, 2015 (Filed With SEC on March 8, 2016)

5,454,546 Shares Vital Therapies, Inc. Common Stock UNDERWRITING AGREEMENT October 22, 2015 (Filed With SEC on October 23, 2015)

VITAL THERAPIES, INC. OUTSIDE DIRECTOR COMPENSATION POLICY Adopted and approved May 13, 2013 As Amended March 18, 2015 (Filed With SEC on May 12, 2015)

15010 Avenue of Science,Suite 200, San Diego, CA 92128 Tel ###-###-#### Fax ###-###-#### (Filed With SEC on March 20, 2015)

VITAL THERAPIES, INC. 2014 EQUITY INCENTIVE PLAN GLOBAL STOCK OPTION AGREEMENT (Filed With SEC on March 20, 2015)

[] Shares Vital Therapies, Inc. Common Stock UNDERWRITING AGREEMENT [], 2014 (Filed With SEC on September 30, 2014)

[] Shares Vital Therapies, Inc. Common Stock UNDERWRITING AGREEMENT [], 2014 (Filed With SEC on April 7, 2014)

15222 B Avenueof Science, San Diego, CA 92128 Tel ###-###-#### Fax ###-###-#### (Filed With SEC on April 3, 2014)

15010 Avenueof Science, Suite 200, San Diego, CA 92128 Tel ###-###-#### Fax ###-###-#### (Filed With SEC on April 3, 2014)

Appendix A ARBITRATION AGREEMENT (Filed With SEC on March 11, 2014)

VITAL THERAPIES, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on March 11, 2014)

VITAL THERAPIES, INC. Non-Employee Director Compensation Policy (Filed With SEC on November 15, 2013)

[] Shares Vital Therapies, Inc. Common Stock UNDERWRITING AGREEMENT [], 2013 (Filed With SEC on November 6, 2013)

Additional abbreviations may also be used though not in the above list. (Filed With SEC on November 6, 2013)

VITAL THERAPIES, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on November 6, 2013)

15222 B Avenueof Science, San Diego, CA 92128 Tel ###-###-#### Fax ###-###-#### (Filed With SEC on November 6, 2013)

15222 B Avenue ofScience, San Diego, CA 92128 Tel ###-###-#### Fax ###-###-#### (Filed With SEC on November 6, 2013)

15222 B Avenue of Science, San Diego, CA 92128 Tel ###-###-#### Fax ###-###-#### (Filed With SEC on November 6, 2013)

VITAL THERAPIES, INC. 2013 EQUITY INCENTIVE PLAN (Filed With SEC on November 6, 2013)

VITAL THERAPIES, INC. FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT August 28, 2013 TABLE OF CONTENTS (Filed With SEC on October 11, 2013)

INVESTORS RIGHTS AGREEMENT (Filed With SEC on October 11, 2013)

AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on October 11, 2013)

VITAL THERAPIES, INC. 2012 STOCK OPTION PLAN (amended April 26, 2012) (amended September 25, 2012) (amended July 2, 2013) (amended September 9, 2013) (Filed With SEC on October 11, 2013)

VITAL THERAPIES, INC. EXECUTIVE INCENTIVE COMPENSATION PLAN Adopted by the Board of Directors on July 8, 2013 (Filed With SEC on October 11, 2013)

VITAL THERAPIES, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENT (Filed With SEC on October 11, 2013)

STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASEMODIFIED NET AMERICAN INDUSTRIAL REAL ESTATE ASSOCIATION (Filed With SEC on October 11, 2013)

STANDARD OFFICE LEASE BY AND BETWEEN ARDEN REALTY LIMITED PARTNERSHIP, a Maryland limited partnership, AS LANDLORD, AND VITAL THERAPIES, INC., a Delaware corporation, AS TENANT... (Filed With SEC on October 11, 2013)

Category

Industry

Companies

Contracts

VITAL THERAPIES INC Contracts & Agreements